Group I metabotropic glutamate receptors in spinal cord injury: Roles in neuroprotection and the development of chronic central pain

Journal of Neurotrauma

Volumn 19, Issue 1, 2002, Pages 23-42

  Mills, Charles D ^a   Johnson, Kathia M ^a   Hulsebosch, Claire E ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Excitotoxicity; Metabotropic glutamate receptors; Neuroprotection; Pain; Spinal cord injury

Indexed keywords

1 AMINO 1,5 INDANDICARBOXYLIC ACID; 2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; 4 CARBOXY 2 METHYLPHENYLGLYCINE; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR ANTAGONIST;

ALLODYNIA; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GRAY MATTER; HYPERALGESIA; LOCOMOTION; MALE; MECHANICAL STIMULATION; NEUROPROTECTION; NONHUMAN; PAIN ASSESSMENT; RAT; SPINAL CORD INJURY; THERMAL STIMULATION; WHITE MATTER;

ANIMALS; BENZOATES; CHRONIC DISEASE; EXCITATORY AMINO ACID ANTAGONISTS; GLYCINE; HYPERALGESIA; LOCOMOTION; MALE; NEUROPROTECTIVE AGENTS; NEUROTOXINS; PAIN; PAIN THRESHOLD; PHYSICAL STIMULATION; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE; SPINAL CORD INJURIES;

EID: 0036158964     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/089771502753460213     Document Type: Article

References (114)

1. Glutamate-mediated neuroprotection against N-methyl-D-aspartate toxicity: A role for metabotropic glutamate receptors
2. Role of group I metabotropic glutamate receptors in traumatic spinal cord white matter injury
3. Activation of NMDA receptors reverses desensitization of mGluR5 in native and recombinant systems
4. Differential distribution of metabotropic glutamate receptors 1a, 1b, and 5 in the rat spinal cord
5. Quisqualate metabotropic receptors modulate NMDA currents and facilitate induction of long-term potentiation through protein kinase C
6. Clinical management of chronic pain in spinal cord injury
7. Chronic changes in the response of cells in adult cat dorsal horn following partial deafferentation: The appearance of responding cells in a previously non-responding region
8. A sensitive and reliable locomotor rating scale for open field testing in rats
9. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man
10. Intrathecal NMDA and non NMDA receptor antagonists reduce mechanical but not thermal allodynia in a rodent model of chronic central pain after spinal cord injury
11. Central dysesthesias syndrome in spinal cord injury patients
12. Metabotropic glutamate receptors potentiate ionotropic glutamate responses in the rat dorsal horn
13. Disturbances in cutaneous sensibility in patients with central pain caused by the spinal cord lesions of syringomyelia
14. Activation of metabotropic glutamate receptors coupled to inositol phospholipid hydrolysis amplifies NMDA-induced neuronal degeneration in cultured cortical cells
15. Metabotropic glutamate receptors and neurodegeneration
16. Neuroprotective activity of the potent and selective mGlula metabotropic glutamate receptor antagonist, (+)-2-methyl-4 carboxyphenyglycine (LY367385): Comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlu 1a and mGlu5 receptors
17. Selective blockade of metabotropic glutamate receptor subtype 5 is neuroprotective
18. The inhibitory mGluR agonist, S-4-carboxy-3-hydroxy-phenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death
19. Pain and depression in acute traumatic spinal cord injury: Origins of chronic problematic pain?
20. Expression and coupling to polyphosphoinositide hydrolysis of group-1 metabotropic glutamate receptors in early postnatal and adult rat brain
21. Anti-convulsant actions of LY 367685 ([+]-2-methyl-4-carboxyphenylglycine) and AIDA ([RS]-1-aminoindan-1, 5-dicarboxylic acid)
22. Anticonvulsant activity of two metabotropic glutamate Group I antagonists selective for the mGlu5 receptor: 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), and (E)6-methyl-2-styryl-pyridine (SIB 1893)
23. Chronic central pain after spinal cord injury
24. Spinal cord injury and anti-NGF treatment results in changes in CGRP density and distribution in the dorsal horn in the rat
25. Pharmacology and functions of metabotropic glutamate receptors
26. The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats
27. Activation of metabotropic glutamate receptors prevents cultured neurons against apoptosis induced by beta-amyloid peptide
28. The metabotropic glutamate receptor mGlu5 controls the onset of developmental apoptosis in cultured cerebellar neurons
29. The interaction between plasma membrane depolarization and glutamate receptor activation in the regulation of cytoplasmic free calcium in cultured cerebellar granule cells
30. AIDA, a group I metabotropic glutamate receptor antagonist, reduces the ischemia-induced neuronal loss
31. Clinical characteristics of central (Dysesthetic) pain in spinal cord injury patients
32. Plasticity in the spinal cord sensory map following peripheral nerve injury in rats
33. Characterization of variables defining hindpaw withdrawal latency evoked by radiant thermal stimuli
34. Peripheral and spinal antihyperalgesic activity of SIB-1757, a metabotropic glutamate receptor (mGluR5) antagonist, in experimental neuropathic pain in rats
35. 2+ stores and ion channels in neurons
36. Evidence against a permissive role of metabotropic glutamate receptor 1 in acute excitotoxicity
37. The contribution of metabotropic glutamate receptors to formalin-induced nociception
38. Comparison of nociceptive effects produced by intrathecal administration of mGluR agonists
39. Activation of group I mGluRs potentiates NMDA responses in rat hippocampal slices
40. In vivo antinociceptive activity of anti-rat mGluR1 and mGluR5 antibodies in rats
41. Activation of metabotropic glutamate receptors produces reciprocal regulation of ionotropic glutamate and GABA responses in the nucleus of the tractus solitarius of the rat
42. A monitored contusion model of spinal cord injury in the rat
43. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis
44. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
45. Signal transduction pathways involved in the acute potentiation of NMDA responses by 1S, 3R-ACPD in rat hippocampal slices
46. Positive feedback of glutamate exocytosis by metabotropic presynaptic receptor stimulation
47. Functional switch from facilitation to inhibition in the control of glutamate release by metabotropic glutamate receptors
48. The effects of arterial blood gas values on lesion volumes in a graded rat spinal cord contusion model
49. Quantitation of sprouting of dorsal root axons
50. Sprouting of dorsal root axons
51. Rodent model of chronic central pain after spinal cord contusion injury
52. Metabotropic glutamate receptors in superficial laminae of the rat dorsal horn
53. 14C]γ-aminobutyric acid in rat solitary nucleus
54. Metabotropic glutamate receptor subtypes 1 and 5 are activators of extracellular signal-regulated kinase signaling required for inflammatory pain in mice
55. Protein kinase C-mediated enhancement of NMDA currents by metabotropic glutamate receptors in Xenopus oocytes
56. Neuroprotective actions of novel and potent ligands of group I and group II metabotropic glutamate receptors
57. Sprouting of primary afferent fibers after spinal cord transection in the rat
58. Neutralizing intraspinal nerve growth factor blocks autonomic dysreflexia caused by spinal cord injury
59. Experimental spinal cord contusion injury: Comparison of different outcome parameters
60. Characteristics of somatotopic organization and spontaneous neuronal activity in the region of the thalamic principal sensory nucleus in patients with spinal cord transection
61. Excitatory amino acids rise to toxic levels upon impact injury to the rat spinal cord
62. Intradendritic release of calcium induced by glutamate in cerebellar Purkinje cells
63. Spinal cord injuries-clinical, functional, and emotional status
64. Pharmacological characterization of the quisqualate receptor coupled to phospholipase C (Qp) in striatal neurons
65. Apotosis and necrosis occur in separate neuronal populations in hippocampus and cerebellum after ischemia and are associated with differential alterations in metabotropic glutamate receptor signaling pathways
66. Changes in amino acid concentrations over time and space around an impact injury and their diffusion through the rat spinal cord
67. Evidence that reversed glutamate uptake contributes significantly to glutamate release following experimental injury to the rat spinal cord
68. Denervation induced intraspinal synaptogenesis of calcitonin gene-related peptide containing primary afferent terminals
69. Intraspinal sprouting of calcitonin gene-related peptide containing primary afferents after deafferentation in the rat
70. Application of the Cavalieri principle and vertical sections method to lung: Estimation of volume and pleural surface area
71. AIDA reduces glutamate release and attenuates mechanical allodynia after spinal cord injury
72. Changes in metabotropic glutamate receptor expression following spinal cord injury
73. Strain and model differences in behavioral outcomes following spinal cord injury in rat
74. Changes in exploratory behavior as a measure of chronic central pain following spinal cord injury
75. Pharmacolgical characterization of 1-aminoindan 1, 5-dicarboxylic acid, a potent mGluR1 antagonist
76. mGluR modulation of post-traumatic neuronal death: Role of NMDA receptors
77. 2+ mobilization in hippocampal neurosn
78. 2+ homeostasis in hippocampal neurons
79. Requirement of metabotropic glutamate receports for the generation of inflamamation-evoked hyperexcitability in rat spinal cord neurons
80. Role of metabotropic glutamate receptor subtype mGluR1 in brief nociception and central sensitization of primate STT cells
81. Group-I metabotropic glutamate receptors: Hypotheses to explain their dual role in neurotoxicity and neuroprotection
82. Spinal cord contusion in the rat: Morphometric analyses of alterations in the spinal cord
83. Correlative analysis of lesion development and functional status after graded spinal cord contusive injuries in the rat
84. A new method of quantifying the extent of tissue loss following spinal cord injury in the rat
85. Biomechanical analysis of spinal cord injury and functional loss
86. Alteration in extracellular amino acids after traumatic spinal cord injury
87. Protection with metabotropic glutamate 1 receptor antagonists in models of ischemic neuronal death: Time-course and mechanisms
88. Review: Neurotransmitter receptors I-the metabotropic glutamate receptors: Structure and functions
89. The types of neuron which contain protein kinase C gamma in rat spinal cord
90. Cyclosporin A treatment following spinal cord injury to the rat: Behavioral effects and stereological assessment of tissue sparing
91. Activation of postsynaptic metabotropic glutamate receptors by trans-ACPD hyperpolarizes neurons of the basolateral amygdala
92. Neuroprotection by group I metabotropic glutamate receptor antagonists in forebrain ischemia of gerbil
93. Psycho-social aspects of chronic pain in spinal cord injury
94. Spontaneous hyperactivity in the medial and intralaminar thalamic nuclei of patients with deafferentation pain
95. Chronic pain in a community-based sample of men with spinal cord injury: Prevalence, severity, and relationship with impairment, disability, handicap and subjective well-being
96. Switch from facilitation to inhibition of excitatory synaptic transmission by group I mGluR desensitization
97. Understanding chronic pain after spinal cord injury
98. Protein phosphatase 1 and 2A inhibitors prolong the switch in the control of glutamate release by group I metabotropic glutamate receptors: Characterization of the inhibitory pathway
99. The effects of G-protein kinase inhibitors on the behavioral responses of rats to intradermal injection of capsaicin
100. Capsaicin-induced sensitization of primate spinothalamic tract cells is prevented by a protein kinase C inhibitor
101. Antagonists for group-I mGluRs attenuate excitotoxic neuronal death in cortical cultures
102. Deafferentation syndromes in humans: A general discussion
103. Deafferentation and central pain
104. 5 subtype positively modulate neuronal glutamate release in the rat forebrain in vitro
105. 5 metabotropic glutamate receptor distribution in rat and human spinal cord: A developmental study
106. Spinal contusion induces changes in immunodensity of neuronal and glial glutamate transporters
107. Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain
108. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states
109. Evidence for a role of metabotropic glutamate receptors in sustained nociceptive inputs to rat dorsal horn neurons
110. The involvement of metabotropic glutamate receptors and their intracellular signaling pathways in sustained nociceptive transmission in rat dorsal horn neurons
111. Behavioral and electrophysiological evidence supporting a role for group 1 metabotropic glutamate receptors in mediation of nociceptive inputs to the rat spinal cord
112. Antisense ablation of type I metabotropic glutamate receptor mGluR1 inhibits spinal nociceptive transmission
113. Pharmacological and immunocytochemical characterization of metabotropic glutamate receptors in cultured Purkinje cells